Literature DB >> 25770180

Association between early airway damage-associated molecular patterns and subsequent bacterial infection in patients with inhalational and burn injury.

Robert Maile1, Samuel Jones2, Yinghao Pan3, Haibo Zhou3, Ilona Jaspers4, David B Peden4, Bruce A Cairns5, Terry L Noah4.   

Abstract

Bacterial infection is a major cause of morbidity affecting outcome following burn and inhalation injury. While experimental burn and inhalation injury animal models have suggested that mediators of cell damage and inflammation increase the risk of infection, few studies have been done on humans. This is a prospective, observational study of patients admitted to the North Carolina Jaycee Burn Center at the University of North Carolina who were intubated and on mechanical ventilation for treatment of burn and inhalational injury. Subjects were enrolled over a 2-yr period and followed till discharge or death. Serial bronchial washings from clinically indicated bronchoscopies were collected and analyzed for markers of tissue injury and inflammation. These include damage-associated molecular patterns (DAMPs) such as hyaluronic acid (HA), double-stranded DNA (dsDNA), heat-shock protein 70 (HSP-70), and high-mobility group protein B-1 (HMGB-1). The study population was comprised of 72 patients who had bacterial cultures obtained for clinical indications. Elevated HA, dsDNA, and IL-10 levels in bronchial washings obtained early (the first 72 h after injury) were significantly associated with positive bacterial respiratory cultures obtained during the first 14 days postinjury. Independent of initial inhalation injury severity and extent of surface burn, elevated levels of HA dsDNA and IL-10 in the central airways obtained early after injury are associated with subsequent positive bacterial respiratory cultures in patients intubated after acute burn/inhalation injury.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  acute lung injury; burn injury; inhalational injury; innate immunology; respiratory infection

Mesh:

Substances:

Year:  2015        PMID: 25770180      PMCID: PMC4421787          DOI: 10.1152/ajplung.00321.2014

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  31 in total

Review 1.  DAMPs, PAMPs and alarmins: all we need to know about danger.

Authors:  Marco E Bianchi
Journal:  J Leukoc Biol       Date:  2006-10-10       Impact factor: 4.962

2.  Circulating mitochondrial DAMPs cause inflammatory responses to injury.

Authors:  Qin Zhang; Mustafa Raoof; Yu Chen; Yuka Sumi; Tolga Sursal; Wolfgang Junger; Karim Brohi; Kiyoshi Itagaki; Carl J Hauser
Journal:  Nature       Date:  2010-03-04       Impact factor: 49.962

3.  Effect of IL-10 on neutrophil recruitment and survival after Pseudomonas aeruginosa challenge.

Authors:  Lei Sun; Ren-Feng Guo; Michael W Newstead; Theodore J Standiford; Demetrio R Macariola; Thomas P Shanley
Journal:  Am J Respir Cell Mol Biol       Date:  2008-12-18       Impact factor: 6.914

4.  Neutrophils are significant producers of IL-10 during sepsis.

Authors:  Kevin R Kasten; Jared T Muenzer; Charles C Caldwell
Journal:  Biochem Biophys Res Commun       Date:  2010-01-25       Impact factor: 3.575

5.  The sepsis seesaw: tilting toward immunosuppression.

Authors:  Richard S Hotchkiss; Craig M Coopersmith; Jonathan E McDunn; Thomas A Ferguson
Journal:  Nat Med       Date:  2009-05       Impact factor: 53.440

6.  Toll-like receptor 2 and 4 ligation results in complex altered cytokine profiles early and late after burn injury.

Authors:  Bruce A Cairns; Carie M Barnes; Stefan Mlot; Anthony A Meyer; Robert Maile
Journal:  J Trauma       Date:  2008-04

7.  The utility of bronchoscopy after inhalation injury complicated by pneumonia in burn patients: results from the National Burn Repository.

Authors:  John Alfred Carr; Bart D Phillips; William M Bowling
Journal:  J Burn Care Res       Date:  2009 Nov-Dec       Impact factor: 1.845

8.  Severity of burn injury and sepsis determines the cytokine responses of bone marrow progenitor-derived macrophages.

Authors:  Mitchell J Cohen; Colleen Carroll; Li-Ke He; Kuzhali Muthu; Richard L Gamelli; Stephen B Jones; Ravi Shankar
Journal:  J Trauma       Date:  2007-04

9.  A murine model of sepsis following smoke inhalation injury.

Authors:  Matthias Lange; Atsumori Hamahata; Daniel L Traber; Aimalohi Esechie; Collette Jonkam; Kamna Bansal; Yoshimitsu Nakano; Lillian D Traber; Perenlei Enkhbaatar
Journal:  Biochem Biophys Res Commun       Date:  2009-12-28       Impact factor: 3.575

10.  Expression of cell surface receptors and oxidative metabolism modulation in the clinical continuum of sepsis.

Authors:  Paulo S Martins; Milena K C Brunialti; Leandro S W Martos; Flavia R Machado; Murillo S Assunçao; Sergio Blecher; Reinaldo Salomao
Journal:  Crit Care       Date:  2008-02-13       Impact factor: 9.097

View more
  19 in total

Review 1.  Emerging concepts in smooth muscle contributions to airway structure and function: implications for health and disease.

Authors:  Y S Prakash
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-10-14       Impact factor: 5.464

2.  One-hit wonder: Late after burn injury, granulocytes can clear one bacterial infection but cannot control a subsequent infection.

Authors:  Laurel B Kartchner; Cindy J Gode; Julia L M Dunn; Lindsey I Glenn; Danté N Duncan; Matthew C Wolfgang; Bruce A Cairns; Robert Maile
Journal:  Burns       Date:  2019-03-02       Impact factor: 2.744

3.  Blocking CXCL1-dependent neutrophil recruitment prevents immune damage and reduces pulmonary bacterial infection after inhalation injury.

Authors:  Julia L M Dunn; Laurel B Kartchner; Wesley H Stepp; Lindsey I Glenn; Madison M Malfitano; Samuel W Jones; Claire M Doerschuk; Robert Maile; Bruce A Cairns
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-01-25       Impact factor: 5.464

Review 4.  Biomarkers in pediatric acute respiratory distress syndrome.

Authors:  Erin F Carlton; Heidi R Flori
Journal:  Ann Transl Med       Date:  2019-10

5.  Free actin impairs macrophage bacterial defenses via scavenger receptor MARCO interaction with reversal by plasma gelsolin.

Authors:  Christine M Ordija; Terry Ting-Yu Chiou; Zhiping Yang; Glen M Deloid; Melina de Oliveira Valdo; Zhi Wang; Alice Bedugnis; Terry L Noah; Samuel Jones; Henry Koziel; Lester Kobzik
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-04-06       Impact factor: 5.464

6.  Inhalation Injury: Unmet Clinical Needs and Future Research.

Authors:  Kiran Dyamenahalli; Gaurav Garg; Jeffrey W Shupp; Paulius V Kuprys; Mashkoor A Choudhry; Elizabeth J Kovacs
Journal:  J Burn Care Res       Date:  2019-08-14       Impact factor: 1.845

7.  Mammalian target of rapamycin regulates a hyperresponsive state in pulmonary neutrophils late after burn injury.

Authors:  Julia L M Dunn; Laurel B Kartchner; Karli Gast; Marci Sessions; Rebecca A Hunter; Lance Thurlow; Anthony Richardson; Mark Schoenfisch; Bruce A Cairns; Robert Maile
Journal:  J Leukoc Biol       Date:  2018-02-02       Impact factor: 4.962

Review 8.  The role of hyaluronan in the pathobiology and treatment of respiratory disease.

Authors:  Stavros Garantziotis; Martin Brezina; Paolo Castelnuovo; Lorenzo Drago
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-01-08       Impact factor: 5.464

9.  High molecular weight hyaluronan ameliorates allergic inflammation and airway hyperresponsiveness in the mouse.

Authors:  Collin G Johnson; Vandy P Stober; Jaime M Cyphert-Daly; Carol S Trempus; Gordon P Flake; Valbona Cali; Israr Ahmad; Ronald J Midura; Mark A Aronica; Sadis Matalon; Stavros Garantziotis
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-09-06       Impact factor: 5.464

10.  Plasma extracellular vesicles released after severe burn injury modulate macrophage phenotype and function.

Authors:  Micah L Willis; Cressida Mahung; Shannon M Wallet; Alexandra Barnett; Bruce A Cairns; Leon G Coleman; Robert Maile
Journal:  J Leukoc Biol       Date:  2021-08-03       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.